AVVH (AVVAA World Health Care Products) Operating Income: $-3.17 Mil (TTM As of May. 2007)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AVVAA World Health Care Products Operating Income?

AVVAA World Health Care Products AVVH Operating Income is $-3.17 Mil as of May. 2007.

AVVAA World Health Care Products's Operating Income for the six months ended in May. 2007 was $-3.17 Mil. Its Operating Income for the trailing twelve months (TTM) ended in May. 2007 was $-3.17 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. AVVAA World Health Care Products's Operating Income for the six months ended in May. 2007 was $-3.17 Mil. AVVAA World Health Care Products's Revenue for the six months ended in May. 2007 was $0.10 Mil. Therefore, AVVAA World Health Care Products's Operating Margin % for the quarter that ended in May. 2007 was -3,296.88%.

AVVAA World Health Care Products's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. AVVAA World Health Care Products's annualized ROC % for the quarter that ended in May. 2007 was -28.77%. AVVAA World Health Care Products's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2007 was -984.45%.


AVVAA World Health Care Products  (OTCPK:AVVH) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

AVVAA World Health Care Products's annualized ROC % for the quarter that ended in May. 2007 is calculated as:

ROC % (Q: May. 2007 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2006 ) + Invested Capital (Q: May. 2007 ))/ count )
=-3.165 * ( 1 - % )/( (13.14 + 8.863)/ 2 )
=-3.165/11.0015
=-28.77 %

where

Note: The Operating Income data used here is one times the annual (May. 2007) data.

2. Joel Greenblatt's definition of Return on Capital:

AVVAA World Health Care Products's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2007 is calculated as:

ROC (Joel Greenblatt) %(Q: May. 2007 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: May. 2006  Q: May. 2007
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.165/( ( (0.328 + max(-12.051, 0)) + (0.315 + max(-12.812, 0)) )/ 2 )
=-3.165/( ( 0.328 + 0.315 )/ 2 )
=-3.165/0.3215
=-984.45 %

where Working Capital is:

Working Capital(Q: May. 2006 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.012 + 0.352 + 0.009) - (1.019 + 0 + 11.405)
=-12.051

Working Capital(Q: May. 2007 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.028 + 0 + 0.016) - (6.273 + 0 + 6.583)
=-12.812

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (May. 2007) EBIT data.

3. Operating Income is also linked to Operating Margin %:

AVVAA World Health Care Products's Operating Margin % for the quarter that ended in May. 2007 is calculated as:

Operating Margin %=Operating Income (Q: May. 2007 )/Revenue (Q: May. 2007 )
=-3.165/0.096
=-3,296.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


AVVAA World Health Care Products Operating Income Related Terms


AVVAA World Health Care Products Operating Income Historical Data

* Premium members only.

The historical data trend for AVVAA World Health Care Products's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVVAA World Health Care Products Operating Income Chart

AVVAA World Health Care Products Annual Data
Trend May00 May01 May02 May03 May04 May05 May06 May07
Operating Income
Get a 7-Day Free Trial -0.81 -2.30 -2.83 -2.64 -3.17

AVVAA World Health Care Products Semi-Annual Data
May00 May01 May02 May03 May04 May05 May06 May07
Operating Income Get a 7-Day Free Trial -0.81 -2.30 -2.83 -2.64 -3.17

AVVAA World Health Care Products Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Income for the trailing twelve months (TTM) ended in May. 2007 was $-3.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of $-3.17 Mil mean?
AVVAA World Health Care Products (AVVH) has a Operating Income of $-3.17 Mil as of May. 2007. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on AVVAA World Health Care Products and its competitors.
Is AVVAA World Health Care Products' Operating Income too high?
AVVAA World Health Care Products' current Operating Income is $-3.17 Mil.
How does AVVAA World Health Care Products' Operating Income compare to PAPL and AAMCF?
AVVAA World Health Care Products' Operating Income of $-3.17 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Banks company?
A good Operating Income depends on the Banks industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on AVVAA World Health Care Products and its competitors. AVVAA World Health Care Products's current Operating Income is $-3.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVVAA World Health Care Products stock overvalued right now?
AVVAA World Health Care Products (AVVH) has a current Operating Income of $-3.17 Mil. The current Operating Income is $-3.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For AVVAA World Health Care Products (AVVH), the current Operating Income is $-3.17 Mil as of May. 2007. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AVVAA World Health Care Products Business Description

Address 1001 West Loop South, Suite 803, Houston, TX, USA, 77027
AVVAA World Health Care Products Inc is a capital financing company for real estate borrowings.